Common Stock and Warrants - Private Placement of Common Stock (Details) $ / shares in Units, $ in Millions		3 Months Ended	9 Months Ended
	Sep. 21, 2023 USD ($) D $ / shares shares	Sep. 30, 2023 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 $ / shares	Dec. 31, 2023 $ / shares
Private Placement
Private Placement of Common Stock
Aggregate Common units sold | shares	6,852,811
Number of Prefunded Units to sell | shares	503,058
Common unit purchase price (in dollar per unit)	$ 1.4275
Prefunded unit purchase price (in dollar per unit)	$ 1.4265
Proceeds from private placement and warrants | $	$ 10.5
Private placement fees | $	$ 1.1
Amount allocated to issuance of the common stock | $		$ 0.2	$ 0.2
Class A Common stock
Private Placement of Common Stock
Common stock, par value (in dollar per share)				$ 0.001	$ 0.001
Class A Common stock | Private Placement
Private Placement of Common Stock
Number of common stock per warrant (in shares) | shares	1.5
Amount allocated to issuance of the common stock | $	$ 0.4		$ 0.2
Common stock warrants | Private Placement
Private Placement of Common Stock
Number of common stock per unit | shares	1
Number of trading days after clearance by the U.S. Food & Drug Administration of the Company's CanGarooRM antibiotic-eluting biologic envelope to exercise warrant | D	30
Exercise price (in dollar per share)	$ 1.4275
2023 Prefund Warrants
Private Placement of Common Stock
Exercise price (in dollar per share)				$ 0.001
2023 Prefund Warrants | Private Placement
Private Placement of Common Stock
Proceeds from private placement and warrants | $	$ 8.6
Prefunded Warrants | Private Placement
Private Placement of Common Stock
Number of common stock per warrant (in shares) | shares	1
Exercise price (in dollar per share)	$ 0.001